Volume 116, Issue 1 p. 6-8
Comment

A novel randomised controlled trial design in prostate cancer

Eleni Anastasiadis

Corresponding Author

Eleni Anastasiadis

Clinical Effectiveness Unit (CEU), Royal College of Surgeons of England and London School of Hygiene and Tropical Medicine, London, UK

Correspondence: Eleni Anastasiadis, The Clinical Effectiveness Unit, The Royal College of Surgeons of England, 35-43 Lincoln's Inn Fields, London WC2A 3PE, UK.

e-mail: [email protected]

Search for more papers by this author
Hashim Uddin Ahmed

Hashim Uddin Ahmed

Division of Surgery and Interventional Science, University College London, London, UK

Department of Urology, University College London Hospitals NHS Foundation Trust, London, UK

Search for more papers by this author
Clare Relton

Clare Relton

School of Health and Related Research (Public Health section), University of Sheffield, Sheffield, UK

Search for more papers by this author
Mark Emberton

Mark Emberton

Division of Surgery and Interventional Science, University College London, London, UK

Department of Urology, University College London Hospitals NHS Foundation Trust, London, UK

Search for more papers by this author
First published: 14 March 2014
Citations: 4
No abstract is available for this article.